Supporting Information
Estimating the potential toxicity of chiral diclofop-methyl: Mechanistic insight into
the enantioselective behavior
Fei Ding a, b, Wei Peng c, *, Yu-Kui Peng d, Bing-Qi Liu e
a Department of Environmental Engineering, Chang’an University, Xi’an 710054,
China
b Key Laboratory of Subsurface Hydrology and Ecological Effect in Arid Region of
Ministry of Education, Chang’an University, No. 126 Yanta Road, Yanta District,
Xi’an 710054, China
c State Key Laboratory of Physical Chemistry of Solid Surfaces and Fujian Provincial
Key Laboratory of Theoretical and Computational Chemistry, College of Chemistry
and Chemical Engineering, Xiamen University, Xiamen 361005, China
d Center for Food Quality Supervision, Inspection & Testing, Ministry of Agriculture
and Rural Affairs, Northwest A&F University, Yangling 712100, China
e Department of Agricultural Chemistry, Qingdao Agricultural University, Qingdao
266109, China
*Corresponding AuthorPhone/fax: +86-29-87092367E-mail: [email protected]
Supplementary Protocols:
1
1
12
Time-Resolved Fluorescence Spectroscopy. Time-resolved fluorescence lifetime
was measured with a FLS1000 Photoluminescence Spectrometer (Edinburgh
Instruments, United Kingdom), utilizing the time-correlated single photon counting
mode with a hydrogen flash lamp excitation source, in air equilibrated solution at an
ambient temperature. The excitation wavelength was 280 nm and the number of
counts collected in the channel of maximum intensity was 4,000. The instrument
response function (IRF) was gauged exploiting Ludox to scatter light at the excitation
wavelength. The data were analyzed with a nonlinear least-squares iterative method
using the new Fluoracle® software package (Edinburgh Instruments, United
Kingdom), IRF was deconvoluted from the experimental data, and the resolution limit
after deconvolution was 0.2 ns. The value of χ2 (0.9~ 1.2), the Durbin-Watson
parameter (greater than 1.7), as well as a visual inspection of the residuals were
employed to judge how well the computed decay fit the data. Average fluorescence
lifetime (τ) for multiexponential function fittings were acquired from the following
relation (Patel and Datta, 2007; Henry et al., 2014; Zahid et al., 2019):
(1)
where τi are fluorescence lifetimes and Ai are their relative amplitudes, with i variable
from 1 to 2.
Site-Specific Competitive Assay. Enantioselective bioreaction domain studies
between target protein and diclofop-methyl enantiomers in the existence of three
2
23
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
34
classic site markers (warfarin, diazepam, and digitoxin) were executed using the
fluorescence titration approach. The concentration of target protein and site markers
were held in equimolar (1.0 μM), then diclofop-methyl enantiomers were respectively
added to the protein-site markers mixtures. An excitation wavelength of 295 nm was
selected and the fluorescence emission wavelength was registered from 300 to 450
nm.
Circular Dichroism Spectra. Circular dichroism (CD) spectra were performed
with a J-1500 Circular Dichroism Spectrophotometer (Jasco, Japan) equipped with a
microcomputer, the apparatus was sufficiently purged with 99.9% dry nitrogen gas
before starting the instrument and then it was calibrate with d-10-camphorsulfonic
acid. All the CD spectra were conducted at 298 K with a single-position Peltier
thermostatted cell holders (PTC-517) attached to a water bath with an accuracy of
±0.1 oC. Each spectrum was recorded with use of a precision quartz cuvette of 10 mm
path length and taken at wavelengths between 200 and 260 nm range that provides a
signal extremely sensitive to small secondary conformational disturbances. Every
determination was the average of five continual scans encoded with 0.1 nm step
resolution and got at a speed of 50 nm min-1 and response time of 1.0 s. All observed
CD data were baseline subtracted for buffer and the evaluation of the secondary
structure components was gained by employing the Spectra ManagerTM Suite (Jasco,
Japan), which calculates the different designations of secondary structures by
comparison with CD spectra, determined from diverse proteins for which high-quality
X-ray diffraction data are available (Johnson, 1999; Goormaghtigh et al., 2009;
3
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
56
Pescitelli et al., 2014).
Molecular Dynamics Simulation. Molecular dynamics (MD) simulation of the
protein-diclofop-methyl enantiomers was performed using a versatile GROMACS
package, version 2019, with the GROMOS96 54A7 force field (van der Spoel et al.,
2005; Huang et al., 2011; Kutzner et al., 2011; Schmid et al., 2011; Kutzner et al.,
2018). Simulation process was run under physiological conditions (pH=7.4), and the
amino acid residues possessed acidity and basicity were adjusted to the protonation
states at neutrality condition. Initial conformations of protein and diclofop-methyl
enantiomers were, respectively, taken from the original X-ray diffraction crystal
structure that was solved at 2.5 Å resolution (entry codes 1H9Z) and the optimal
structure originated from molecular docking (Petitpas et al., 2001). The topology of
protein was yielded by GROMACS program directly, whereas diclofop-methyl
enantiomers by PRODRG2.5 Server (van Aalten et al., 1996; Schüttelkopf and van
Aalten, 2004). The simulation system was solvated with a periodic cubic box (the
volume is 8.771×5.061×8.664 nm3) filled with TIP3P water molecules and an
approximate number (14) of sodium counterion to neutralize the charge (Jorgensen et
al., 1983; Price and Brooks III, 2004). Totally, there are 43,648 crystallographic
solvent molecules, and the shortest distance between the adduct and the edge of the
box is set to 10 Å. Simulation was operated using the isothermal-isobaric (NPT)
ensemble with an isotropic pressure of 1 bar, and the temperature of the ligand,
protein and solvent (water and counterion) was separately coupled to an external bath
4
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
78
held at 300 K, utilizing the Berendsen thermostat with 0.1 ps relaxation time
(Berendsen et al., 1984; van Gunsteren and Berendsen, 1984; Berendsen et al., 1986;
Combs, 1988; Rull et al., 1989). The LINCS algorithm was applied to constrain bond
lengths, and the long-range electrostatic interactions beyond 10 Å were modeled using
the Particle Mesh Ewald (PME) method with a grid point density of 0.1 nm and an
interpolation order of 4 (Darden et al., 1993; York et al., 1994; Hess et al., 1997). A
cutoff of 10 Å was utilized for van der Waals’ interactions. The MD integration time
step was 2.0 fs and covalent bonds were not constrained, and the system
configurations were saved every 2.0 ps. To decrease the atomic collisions with each
other, both gradient descent and conjugate gradient algorithm were adopted to
optimize the whole system (Hestenes and Stiefel, 1952; Gonze, 1996). First the
solvated starting structure was preceded by a 5,000-step gradient descent and then by
conjugate gradient energy minimization. Subsequently, 500 ps equilibration with
position restraints runs to remove possible unfavorable interactions between solute
and solvent, and after thorough equilibration, MD simulation was conducted for
50,000 ps. The result of MD simulation was ultimately appeared by Visual Molecular
Dynamics 1.9.4 (Humphrey et al., 1996; Hsin et al., 2008; Burgin et al., 2018), and
the program Discovery Studio Visualizer 4.0 (BIOVIA, San Diego, CA) was used to
exhibit the images of the MD simulation.
5
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
910
Supplementary Results and Discussion:
Elaborate Interpretation of Enantiomeric Bioreaction Mechanism. It is visible
from the macroscopic behavior of the fluorescent biointeraction that the remarkable
enantioselectivity play a vital role in the biorecognition of the macromolecule-optical
isomers. In order to understand such photochemical phenomenon at the microscopic
scale, this story should dissect the inherent mechanism of the stereoselective
fluorescent reaction. As noted earlier, the shrinkage of fluorescence intensity has been
levigated both as a basic phenomenon, and as an origin of clue regarding molecular
biosystems (Žoldák et al., 2017; Carstea et al., 2019). These biological utilizations of
fluorescence evanishment are owing to the biomolecular reactions that lead to
extinguishing (Lakowicz, 2006). Typically both static and dynamic fluorescent
bioreactions request molecular touch between the fluorophore (Trp residue) and
ligand (diclofop-methyl enantiomers). Upon osculation, the fluorophore backs to the
ground-state without emission of a photon. This signifies fluorescence extinction
befalls without any eternal variation in the molecules, viz. without a photochemical
interaction (Lakowicz, 2000; Maity et al., 2019). We can think that the measurements
of fluorescence drop could be exploited to disclose the localization of fluorophores in
biological targets and their permeabilities to ligands, and the rate of collisional
reaction may likewise be utilized to assess the diffusion coefficient of the ligand.
Hence the appearance of fluorescence reduction relies on the chemical properties of
6
858687
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
1112
the independent molecules, and exhaustive decryption of the mechanism of
fluorescent bioreaction might contribute to grasping the secret heart of
enantioselective biological recognition.
This essay used the classical Stern-Volmer equation to process the data of
emission spectra of the fluorophore, and a graphic of F0/F versus [Enantiomers]
produces an intercept of one on the y-axis and a slope equal to KSV (Fig. S3).
Intuitively, a linear Stern-Volmer plot is mostly suggestive of a lone type of
fluorophores, all equivalently approachable to chiral ligand (Eftink, 1991; Green et
al., 1993; Eftink, 1997). In the current situation, the target protein holds the
chromophore, the aromatic Trp-214 residue, which can be bioreacted with diclofop-
methyl enantiomers. In the meantime, the Stern-Volmer picture is linear, which
insinuates that just one class of bioreaction arises. However, it is essential to sense
that the emergence of a linear Stern-Volmer image does not attest that collisional
fluorescence reaction has transpired, for static interaction still conduces to linear
Stern-Volmer profiles. Interestingly, the order of magnitude of the bimolecular
reaction constant kq in the two chiral biosystems was found to be 1012
(1.892/2.838×1012 M-1 s-1), which implies efficient enantiomeric biointeraction
through static pattern, as a bimolecular reaction constant ~1.0×1010 M-1 s-1 could be
regarded as the highest data for the diffusion-governed bioreaction in aqueous phase
(Eftink and Ghiron, 1981; Eftink and Ghiron, 1987; Eftink and Ghiron, 1991). Thus
one may come to the rational verdict that the disappearance of target protein
7
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
1314
fluorescence is static under the circumstances, or rather, the stereoselective toxic
recognition of (R)-/(S)-stereoisomers by biomolecule is predominantly proceeded via
the generation of the biological target-chiral diclofop-methyl conjugate (Bozorgmehr
et al., 2015; Shakibapour et al., 2019; Aseman et al., 2019).
According to the quantitative Stern-Volmer enunciation of emission spectra of the
fluorophore, one might easily see that the enantiomeric biorecognition can occur as a
result of the emergence of a nonfluorescent ground-state adduct (static type) between
the biomacromolecule and chiral diclofop-methyl, and when this bioconjugate absorbs
light it goes back to the ground state without emission of a photon. It is popularly
accepted that static and dynamic fluorescent biointeraction could be discriminated
through their differing reliance on temperature and viscosity, but preferably by
fluorescence lifetime determinations (Choudhury et al., 2015; Tarif et al., 2019).
Ordinarily, in the case of static reaction, the ground-state bioconjugate is formed
between the ground-state fluorophore and the ligand, and the emission intensity will
be dribbled as a result of dropping the number of fluorophore. Regularly, the lifetime
of fluorophore maintains unaltered during fluorescent bioreaction process, since such
biochemical issue does not influence the excited-state of the fluorophore.
Simultaneously, neither the consistencies of fluorophore nor the inner filtering effects
meddle with lifetime measurements (Zhao et al., 2010; Hao et al., 2015; Arnett et al.,
2018). Therefore the examination of fluorescence lifetime of target protein may be
used to divulge the verificatory biointeraction characteristic if the Stern-Volmer map
is apparently linear, and today this physicochemical device has magnificently been
8
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
1516
hired by numbers of research groups to reveal the biorecognitions of functional
biomolecules with variously active substances (Mohan et al., 2019; Mos et al., 2019;
Patel et al., 2019; Sood et al., 2019). Nonetheless, the information of time-resolved
fluorescence lifetime might not only give precise cue about the time dependence of
the biological reaction, but uncloak the main feature of fluorophore environment
(Amaro et al., 2014; Benabou et al., 2019). Accordingly, to pierce the bioreaction
quality between macromolecule and chiral pesticide, and certify the results of
fluorescence emission spectra, the typical time-resolved fluorescence decay curves of
target protein at various molar ratios of diclofop-methyl enantiomers in Tris-HCl
buffer, pH= 7.4, are displayed in Fig. S4, and the corresponding time-resolved
fluorescence lifetimes and their amplitudes are captured in Table S1.
As has been argued, time-resolved fluorescence lifetime of the chromophore is
extremely perceptive with respect to its contiguous environmental alterations, and for
that reason, the detection of fluorescence lifetime variations of the chromophore can
redound to the inspection of numerous biophysical events during the biointeraction,
for instance, charge transfer, dipolar relaxation, molecular rotation, and extirpation of
the fluorophores (Wu et al., 2018; Lahiri et al., 2019; Valadan et al., 2019).
Unmistakably, the fluorescence lifetime decay curves fitted daintily to a biexponential
function, and this phenomenon advocate the existence of rotational isomers which
could be associated with the single electronic transition of fluorophore in equilibrium
state in the tight structure of biomolecule (Beechem and Brand, 1985; Ross and
9
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
1718
Jameson, 2008; Otosu et al., 2010). It may be known from Table S1 that the relative
fluorescence lifetimes of biopolymer are τ1= 3.29 ns and τ2=7.43 ns (χ2= 1.06),
respectively, while in the maximal amount of (R)-/(S)-enantiomers, the relative
fluorescence lifetimes of biomacromolecule are τ1=3.03/2.86 ns and τ2=7.14/7.03 ns
(χ2=1.04/1.01), respectively. Undeniably, the biexponential decay of the aromatic Trp
residue stems from the dual emission from the 1La and 1Lb excited-states, and the
presence of disparate rotamers, concerning the Cα-Cβ or the Cβ-Cγ bond of Trp residue
was endorsed by Szabo and Rayner (1980) to afford the groundwork for unraveling
the biexponential decay. Specifically, a fluorophore in a homogeneous
microenvironment is anticipated to expose monoexponential fluorescence lifetime
decay, while for the zwitterion of Trp residue, it is unearthed frequently that a
fluorophore own a biexponential decay outline, and the molecular clarification might
embrace either ground-state heterogeneity or excited-state bioreactions (Alcala et al.,
1987; McLaughlin and Barkley, 1997; Rolinski et al., 2007). More importantly, there
is a lone style of fluorophore in the current biopolymer, ground-state heterogeneity
can be evoked by the emergence of manifold conformational states of the biological
target, which arouses the fluorophore to experience a different microenvironment and
possess a dissimilar decay time in each conformation (Schneckenburger et al., 1988;
Moors et al., 2008; Ariga et al., 2015). In fact, due to steric effects between the side
10
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
1920
chain of the Trp residue and the backbone of the polypeptide chain, all rotamers are
not absolutely equal. After the formation of the target protein-chiral pesticide
bioconjugates, the biointeraction group closest to the indole segment is the small
amino group, thereby such conformer own the greatest population and the lifetime is
7.43 ns (Periasamy, 2008; Praus et al., 2008; Xie et al., 2011). In contrast, if the amino
and carbonyl groups near the indole ring, this rotamer could hold the brief lifetime of
3.29 ns (Flora et al., 1998; Millar, 2000; Barakat and Patra, 2013). And the elucidation
of conformers in functional macromolecule is circumscribed to the aqueous solution,
and the presence of various Trp residue rotamers has scrupulously been authenticated
by means of other experimental methods such as nuclear magnetic resonance (Yang
and Zhang, 2010; Julien et al., 2012; Williams et al., 2013). So the current job would
not try to assign the individual ingredient of the lifetime of Trp-214 residue, and
conversely the average fluorescence lifetime has been rented to qualitatively probe the
enantioselective biorecognition essence between the biomolecule and optical isomers.
It is so obvious that the mean fluorescence lifetime of target protein is 6.11 ns,
which square with the previous value released by Abou-Zied and Al-Shihi (2008a,
2008b) in a more recent consideration. At various amounts of (R)-/(S)-diclofop-
methyl, the mean fluorescence lifetimes of biopolymer vary from 6.11 ns to 6.10 ns,
τ0/τ≈1, expounding that the contraction of fluorescence intensity of the Trp residue is
largely dominated by static reaction. At the same time, we may palpably heed that the
mean fluorescence lifetime state a slight fluctuation, but the amplitude is in the
acceptable scope. Perhaps such fact originates from the charge transfer from the
11
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
2122
indole ring in the aromatic Trp-214 residue to the neighboring substituent group,
which gives rise to the weak augmentation on biointeraction intensity of the target
protein-chiral diclofop-methyl and then result in the slight reduction in the average
fluorescence lifetime (Pan et al., 2011; Stella, 2011; Pahari et al., 2015). It is
indicative of a teeny dedication of dynamic trait as just the (R)-/(S)-enantiomers that
undergo dynamic bioreaction have been exclusive donation in the diminution of the
fluorescence lifetime. For this reason the time-resolved fluorescence energy transfer
efficiency (E) reckoned from fluorescence lifetimes determinations solely represents
the energy transfer during the dynamic behavior and is harvested based on the
relationship: E=1-τ/τ0, where τ and τ0 are the fluorescence lifetime of Trp residue in
the presence and absence of diclofop-methyl enantiomers, respectively. The sizes of E
computed from time-resolved fluorescence data are calculated to be 0.1637%,
respectively, in the macromolecule-chiral pesticide complexes at a molar ratio of
target protein to (R)-/(S)-stereoisomers of 1︰4. Patently, this value is exceedingly
small, thus one might believe that the phenomenon of energy transfer is bechanced in
the procedure of biological recognition, but the transfer efficiency is terrifically tiny,
nearly negligible. These minute analyses on the basis of the data of time-resolved
fluorescence conform to the thoughtful clarification of fluorescence emission spectra,
site-specific competitive assay, circular dichroism spectra, and computational
toxicology, that is, biorecognition of chiral pesticide with biomacromolecule is
12
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
2324
substantially progressed via static reaction, or the generation of the noncovalent
bioconjugates between the target protein and chiral diclofop-methyl, and the
bioreaction domain of optical isomers is situated in the proximity of the Trp-214
residue (subdomain IIA), accordingly provoking some conspicuous alterations in the
spatial conformation of biopolymer. This tale should surely prompt that although the
conformational transition of the biological target can be actuated by (R)-/(S)-isomers,
multiexponential fluorescence decay manner could be ascribed to the dissimilar
conformations of target protein rather than an apportionment to different Trp residues
in a biomolecule of one conformation at neutral pH (Chen et al., 1991; Stayton and
Sligar, 1991; Siemiarczuk et al., 2004; Albani, 2009; Amiri et al., 2010a, 2010b).
Moreover, we also discerned that the impact of diclofop-methyl enantiomers on time-
resolved fluorescence lifetime decay of the chromophore on target protein has some
distinction, further substantiating the biointeraction of the macromolecule-chiral
pesticide conserve prominent enantioselectivity. And such chiral selectivity retains
diverse influence on the biomolecular conformational variations triggered by unequal
(R)-/(S)-diclofop-methyl and the free energy of the biomacromolecule-optical
isomers. These analytical outcomes matches the elaborate interpretation on the ground
of circular dichroism and molecular modeling, and a comparable narration has been
specified very recently by Abou-Zied et al. (2011, 2012, 2013, 2015) for the
commentary of the biorecognition of hydroxypyridines, hydroxyquinolines, and
hydroxyphenyl benzazoles with available biopolymers by engaging some modern
biophysical experimental techniques such as fluorescence spectroscopy and UV/vis
13
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
2526
absorption spectra.
Stereoselective Biorecognition Domain. From the findings of the fluorescent
bioreaction between biological macromolecule and chiral pesticide, we may observe
clearly that the biointeraction position of diclofop-methyl enantiomers is ascertained
to be located at the propinquity of the fluorophore on target protein, i.e. subdomain
IIA. In order to validate the experimental results, this attempt uses site-specific
competitive assay to concretely illustrate the biorecognition region of (R)-/(S)-
stereoisomers on biological target. With regard to the target protein utilized in the
present affair, the pioneering effort of Sudlow et al. (1973, 1975a, 1975b, 1976) of
competitive binding surveys defined site I and site II as an independent place for some
drugs, with 5-dimethylaminonaphthalene-1-sulfonamide and dansylsarcosine as two
specific markers, but did not allot they to the cavity of the protein molecule. Luckily,
the X-ray diffraction crystallographic consequences of Carter’s (1989, 1990, 1994a,
1994b) laboratory unwrapped the bioreaction patch corresponding to site I and site II
to stand in subdomains IIA and IIIA, respectively. Structurally, site I is known as the
warfarin-azapropazone site, and formed as a placket in subdomain IIA, the solitary
Trp-214 residue of target protein in this domain. The internal wall of the region is
shaped by hydrophobic side chains, whereas the gate to the hole is encompassed by
positively charged residues (He and Carter, 1992; Dockal et al., 1999; Wang et al.,
2013). And analogously, site II corresponds to the hollow of subdomain IIIA, and is
known as the indole-benzodiazepine site, which is approximately the same size as site
I, the inner of the cave is comprised by hydrophobic residues and the outside area
14
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
2728
posed two essential residues (Arg-410 and Tyr-411). In general, site I ligands are
bulky heterocyclic anions with the charge localized in a fairly central position in the
ligand. This discriminates them from the molecules typical of site II, situated in
subdomain IIIA, which are chiefly aromatic and might be neutral; a charge, if subsist,
is anionic and lied more marginally on the ligand (Dockal et al., 2000; Dockal et al.,
2000; Curry, 2009). Nowadays a lot of diverse substances are trusted to situate in the
district labeled site I and site II by Sudlow et al. (1973, 1975a, 1975b, 1976) that they
would be regarded here together in spite of their gigantic variety. A number of them
are therapeutic pharmaceuticals, e.g. azapropazone, indomethacin, phenylbutazone
and warfarin are among the site I agents (Montero et al., 1986; Kragh-Hansen, 1988;
Pinkerton and Koeplinger, 1990; Ryan et al., 2011), while site II compounds contains
clofibrate, diazepam, flufenamic acid and naproxen (Sollenne and Means, 1979;
Zunszain et al., 2008; Ryan et al., 2011). Afterwards, encouraging biochemical proofs
of Kragh-Hansen, Brodersen’s and Tillement’s teams deemed that digitoxin is
different from both of the two Sudlow’s regions, and perch on what was designated as
site III (Brodersen et al., 1977; Tillement et al., 1980; Kragh-Hansen, 1985).
Consequently, for the current discussion, the competitors utilized involved warfarin, a
typical marker for site I, diazepam for site II, and digitoxin for site III.
In the light of the present protocol, this scenario inspect the enantioselective
biointeraction between macromolecule and chiral diclofop-methyl in the existence of
various competitive chemicals, and the relative fluorescence emission intensity (F/F0)
versus (R)-/(S)-diclofop-methyl concentration ([Enantiomers]) figures is manifested
15
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
2930
in Fig. S5. As can be viewed from Fig. S5, both optical isomers could diminish the
emission intensity of the fluorophore when the three site-specific agents present
respectively in the enantiomeric biorecognition systems, but the amplitude of
fluorescence decline has giant divergence. This chemical phenomenon explicated
crystally that (R)-/(S)-enantiomers and site-specific substance may compete for the
bioreaction patch on target protein, and the notable discrepancies in the fluorescence
decrease extent might be noticed in the presence of different competitive ligands.
Evidently, the emission intensity of the fluorophore is respectively rejected
6.874%/10.65% when the (R)-/(S)-diclofop-methyl add to the biomacromolecule-
warfarin conjugate; while the emission strength of the fluorophore will respectively
drop 20.25%/29.04% and 17.87%/26.25% if the (R)-/(S)-isomers emerge in the
biomolecule-diazepam/digitoxin adducts. Doubtlessly, warfarin has the highest
inhibitory degree for the stereoselective recognition of the target protein-chiral
pesticide, or rather, the strongly competitive bioreaction relationship between chiral
pesticide and warfarin is occurred in biopolymer, and further enable the
macromolecule-diclofop-methyl enantiomers to own the smallest biorecognition
intensity. Such event testified that (R)-/(S)-stereoisomers and warfarin indeed act on
the same biointeraction domain, that is they have the uniform ligand reaction position,
subdomain IIA (Sudlow’s site I). It is noteworthy that (R)-/(S)-diclofop-methyl can
still shorten ~ 20% and 25% emission intensity of the fluorophore, respectively,
clarifying that the emersion of diazepam/digitoxin did not have significant
16
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
3132
interference with the enantioselective bioreaction of biomolecule with chiral diclofop-
methyl, or, more exactly, the capital biorecognition area of chiral pesticide and
diazepam/digitoxin is not overlapped on target protein, and the biointeraction region
of the optical isomers is fixed to be located within the Sudlow’s site I, where the
aromatic Trp residue situate in the structural domain on biomacromolecule (Fasano et
al., 2005; Ghuman et al., 2005; Simard et al., 2006). Certainly, the conclusion of the
site-specific competitive assay is not only compatible greatly with the experimental
outcomes of fluorescence spectroscopy, but also in consonance with the upshots of
enantiomeric biological reaction based upon the approach of computational
toxicology.
Conformational Alteration. As previously mentioned, the results of fluorescence
spectroscopy implicated that the enantioselective biorecognition of chiral diclofop-
methyl by target protein could cause remarkable decrease in the emission intensity of
the fluorophore, and such issue alluded that the orderly spatial conformation of
biomolecule has changed to a certain extent, because a conformational alteration of a
biopolymer engendered by ligand bioreaction may commonly bring about a variation
of the fluorescence intensity (Hovius et al., 2000; Akbar et al., 2016; Samokhvalov et
al., 2018). Further, the experimental consequences of site-specific competitive assay
evinced that both optical isomers are centered in the Sudlow’s site I (subdomain IIA)
on biomacromolecule, and this is another smoking gun for macromolecular
conformational changes, as conformational alterations in the present globular protein
are frequently distinct with many site I substances (Kragh-Hansen, 1990; Peters Jr.,
17
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
3334
1995; Yamasaki et al., 1996; Kragh-Hansen et al., 2013). This event was taken to
mean that the “configurational adaptability” embraces more than the adjacent
neighborhood of a ligand and might impact the compactness or decompaction of
structure of the entire protein molecule.
To scrutinize the quantitatively conformational changes of biological target during
the enantiomeric biointeraction, the far-UV CD spectra of biomolecule with different
amounts of (R)-/(S)-stereoisomers were collected in Fig. S6, and secondary structure
contents evaluated based upon raw CD data were gathered in Table S2. It was obvious
that the CD curve of the lone biopolymer presented two negative peaks in the far-UV
region at 208 nm and 222 nm (negative Cotton effect), which are the representative
earmark of the α-helical structure of globular protein (Johnson Jr., 1988; Besley and
Hirst, 1999; Wallace and Janes, 2001). A logical explication is that the negative peaks
between 208 nm and 209 nm and 222 nm and 223 nm are governed via both n→π*
and π→π* transitions of amide groups and are also impressed by the geometries of the
polypeptide backbones (Sreerama and Woody, 1994; Kelly and Price, 2000; Corrêa
and Ramos, 2009). It can be stated in Table S2 that free target protein includes 58.4%
α-helix, 9.3% β-sheet, 10.1% turn and 22.2% random coil; upon biorecognition with
(R)-/(S)-enantiomers, a diminution of α-helix was viewed from 58.4% (free target
protein) to 49.9%/48.5% (target protein-(R)-/(S)-isomers), and then there was a rise in
β-sheet, turn and random coil from 9.3%, 10.1% and 22.2% (free target protein) to
12.1%/12.4%, 12.7%/13.2% and 25.3%/25.9 (target protein-(R)-/(S)-stereoisomers) at
18
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
3536
a molar ratio of target protein to chiral diclofop-methyl of 1︰ 6. Apparently, the
abasement of α-helical constituent with an amplification in the β-sheet, turn and
random coil structures confirmed that diclofop-methyl enantiomers fashions
noncovalent bonds with the residues in the polypeptide chain on target protein, and
then sparking off the destabilization of the regularly spatial conformation in protein
molecule, e.g. some degree of structural protension of target protein after it recognize
optical isomers (Woody, 1995; Greenfield, 2006; Iranfar et al., 2012; Chanphai and
Tajmir-Riahi, 2019). Meanwhile, we could also mark from Table S2 that the influence
of (R)-stereoisomer on the secondary structure of target protein is less than (S)-
stereoisomer, and this is probably because the bioreaction intensity of (S)-
stereoisomer with target protein outweigh (R)-enantiomer, namely, the noncovalent
bonds yielded between (S)-enantiomer and the crucial residues are relatively strong,
and thereby having somewhat large perturbation on the regularly spatial conformation
of target protein. Such biochemical phenomenon further demonstrated that the toxic
biointeraction is guaranteed to possess enantioselectivity when the intrinsic
macromolecule face chiral pesticide in living organisms, and the (R)-/(S)-isomers of
chiral toxicant would produce different effects on biomacromolecular conformation,
whereas the conformation of biopolymer is related inseparably to its biological
function, and so that these optical isomers shall ultimately exhibit various
toxicological effects in the body (Lashuel et al., 2013; Nwamba and Ibrahim, 2014;
Moarefi, 2016).
Besides, it should be noted that the biomolecular conformational alterations
19
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
3738
provoked by (R)-/(S)-diclofop-methyl in the current experimental conditions does not
mean the serious damage in the orderly spatial conformation of target protein, but the
self-regulation of the macromolecular spatial structure so as to qualify diclofop-
methyl enantiomers to act on the bioreaction domain of biological target more perfect.
Thus, strictly speaking, the compact α-helical structure of target protein is still
predominated in the stereoselective biorecognition processes. Practically, such
biological macromolecule is not in a stationary, “platonic” state at physiological pH;
on the contrary, it is imagined as the limber and quickly altering in shape, a “kicking
and screaming, stochastic” biopolymer in the biological organism. As narrated by
Weber (1972, 1975), the overall biomacromolecule welters in ~ 40 ns. The main
reason is that the loop-link structure in biomolecule approves fast distention,
constringency, and flexure, some of it inherent, some of it associated with
biointeraction with ligands. Usually, the cooperative motions of the target protein
molecule to adapt ligand bioreaction arise in 0.1~ 0.3 s (Choi et al., 1990). For
example, Gurd and Rothgeb (1979) deliberated that molecular oxygen, a ligand of Trp
residue fluorescence, may enter the 10 Å chink between helices h1 and h2, underneath
which inheres the single Trp residue of the biopolymer, within 6.0 ns. The outcomes
of previous discussions also learned that much of the flexibility of target protein is the
result of separate integrant movements of segments of the biological molecule
(Benson and Hallaway, 1970; Hvidt and Wallevik, 1972). Meantime, high
20
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
3940
interchangeability of hydrogens is a singular schtick of the macromolecule among
nonenzymatic proteins, and is possibly a fruit of its slack structure and its proclivity
for biorecognition with many substances (Willumsen, 1971; Volynskaya et al., 1994).
Nevertheless, elements of protein are incessantly moving on more swift time ranges
(Hansen et al., 2013; Chattopadhyay and Haldar, 2014), for instance, the sole Trp
residue side chain of target protein, attained by time-resolved fluorescence
spectroscopy, revolves individually at a speedy rate, nearly 10-10 s rotational
correlation time (Munro et al., 1979; Meadows et al., 2014). As a result, the biological
target leased in this task in liquid solution might be viewed as having a unitary frame
whole, but it is likely more authentic to consider it as an assemblage of wriggly,
flexible fragments, often converting in three-dimensional spatial conformation by
unclosing and occluding of primary cranny. Adopting such respiratory mode, and with
plenty of its amino acid side chains continually in motion on a microscale, the
multifunctional biopolymer is well fitted to snatch or emancipate the various bioactive
compounds, e.g. (R)-/(S)-enantiomers of a chiral pesticide that it assimilate, catalyzes,
degrades, distributes, excretes, metabolizes, transports…in the organisms (Abboud et
al., 2017; Horváthy et al., 2017; Neelofar and Ahmad, 2017; Litus et al., 2018;
Rabbani and Ahn, 2019).
21
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
4142
Supplementary Tables:
Table S1Time-resolved fluorescence lifetime of target protein (10 μM) as a function of amounts of diclofop-methyl enantiomers
Enantiomeric biosystems τ1 (ns) τ2 (ns) A1 A2 τ (ns) χ2
Free protein 3.29 7.43 0.32 0.68 6.11 1.06Protein-(R)-diclofop-methyl (1︰2) 3.37 7.22 0.29 0.71 6.10 1.09Protein-(R)-diclofop-methyl (1︰4) 3.03 7.14 0.25 0.75 6.11 1.04Protein-(S)-diclofop-methyl (1︰2) 3.24 7.16 0.27 0.73 6.10 1.03Protein-(S)-diclofop-methyl (1︰4) 2.86 7.03 0.22 0.78 6.11 1.01
224344
Table S2Secondary structure ingredients of target protein (5.0 μM) stereoselective
biorecognition with diclofop-methyl enantiomers at pH=7.4 computed by the Spectra
ManagerTM Suite
Enantiomeric biosystemsSecondary structure components (%)
α-Helix β-Sheet Turn Random Free protein 58.4 9.3 10.1 22.2
Protein-(R)-diclofop-methyl (1︰6) 49.9 12.1 12.7 25.3Protein-(S)-diclofop-methyl (1︰6) 48.5 12.4 13.2 25.9
234546
Supplementary Figures:
Fig. S1. Molecular structures of (R)-diclofop-methyl (A) and (S)-diclofop-methyl (B).
244748
254950
Fig. S2. Calculated Root-Mean-Square Deviation (RMSD) for the diclofop-methyl enantiomers and the backbone Cα atoms of target protein from MD simulation at
temperature of 300 K with respect to their docking results as a function of the simulation time. The blue and red trajectories portray RMSD data for the backbone Cα
atoms of target protein and the diclofop-methyl enantiomers, respectively. Panel (A): target protein-(R)-diclofop-methyl bioconjugate; and panel (B): target protein-(S)-
diclofop-methyl complex.
265152
Fig. S3. Stern-Volmer plot representing fluorescence bioreaction of target protein (1.0
μM) at pH=7.4 and T=298 K in the existence of different amounts of (R)-diclofop-
methyl (black square, ■) and (S)-diclofop-methyl (red circle, ●). Fluorescence
emission intensity was registered at λex=295 nm, and the λem maximum emerged at
345 nm. All data were corrected for diclofop-methyl enantiomers fluorescence and
each point was the mean of three independent observations±S.D. ranging 0.49%-3.95%.
275354
Fig. S4. Time-resolved fluorescence lifetime decays of target protein in Tris-HCl
buffer (pH=7.4) as a function of the concentrations of (R)-diclofop-methyl (panel
(A)) and (S)-diclofop-methyl (panel (B)), respectively. c(target protein)=10 μM,
c(diclofop-methyl enantiomers)=0 (red circle, ●), 20 (green equilateral triangle, ▲),
and 40 (blue inverted equilateral triangle, ▼) μM. The sharp profile on the left (black square, ■) is the lamp pattern.
285556
Fig. S5. Fluorescence inhibitory effects of target protein and target protein-site
markers biosystems at pH=7.4 and T=298 K. Enantioselective biointeraction
isotherm of (R)-diclofop-methyl (panel (A)) and (S)-diclofop-methyl (panel (B)) induced reduction of target protein fluorescence and decrease of target protein-site
markers complexes fluorescence. (Black square, ■): blank; (red circle, ●): warfarin; (green equilateral triangle, ▲): diazepam; and (blue inverted equilateral triangle, ▼): digitoxin. All data were corrected for diclofop-methyl enantiomers fluorescence and
295758
each value was the average of three separate determinations±S.D. ranging 0.21%-2.17%.
Fig. S6. Circular dichroism spectra of the target protein-diclofop-methyl enantiomers
adducts at pH=7.4 and T=298 K, 5.0 μM target protein in the presence of 0 (black
solid line) and 30 μM (red solid line) diclofop-methyl enantiomers. Panel (A): target protein-(R)-diclofop-methyl conjugates; and panel (B): target protein-(S)-diclofop-
methyl systems.
305960
References
Abboud, R., Charcosset, C., Greige-Gerges, H., 2017. Interaction of triterpenoids with
human serum albumin: A review. Chem. Phys. Lipids 207, 260-270.
Abou-Zied, O.K., 2012. Revealing the ionization ability of binding site I of human
serum albumin using 2-(2’-hydroxyphenyl)benzoxazole as a pH sensitive probe.
Phys. Chem. Chem. Phys. 14, 2832-2839.
Abou-Zied, O.K., 2015. Understanding the physical and chemical nature of the
warfarin drug binding site in human serum albumin: Experimental and theoretical
studies. Curr. Pharm. Des. 21, 1800-1816.
Abou-Zied, O.K., Al-Lawatia, N., 2011. Exploring the drug-binding site Sudlow I of
human serum albumin: The role of water and Trp214 in molecular recognition and
ligand binding. ChemPhysChem 12, 270-274.
Abou-Zied, O.K., Al-Lawatia, N., Elstner, M., Steinbrecher, T.B., 2013. Binding of
hydroxyquinoline probes to human serum albumin: Combining molecular
modeling and Förster’s resonance energy transfer spectroscopy to understand
flexible ligand binding. J. Phys. Chem. B 117, 1062-1074.
Abou-Zied, O.K., Al-Shihi, O.I.K., 2008a. Characterization of subdomain IIA binding
site of human serum albumin in its native, unfolded, and refolded states using
small molecular probes. J. Am. Chem. Soc. 130, 10793-10801.
316162
Abou-Zied, O.K., Al-Shihi, O.I.K., 2008b. Steady-state and time-resolved
fluorescence investigation of 2-pyridone and 3-pyridone in solution and their
specific binding to human serum albumin. Proc. SPIE 6867, 68670K.
Akbar, S.M., Sreeramulu, K., Sharma, H.C., 2016. Tryptophan fluorescence
quenching as a binding assay to monitor protein conformation changes in the
membrane of intact mitochondria. J. Bioenerg. Biomembr. 48, 241-247.
Albani, J.R., 2009. Fluorescence lifetimes of tryptophan: Structural origin and relation
with So→1Lb and So→1La transitions. J. Fluoresc. 19, 1061-1071.
Alcala, J.R., Gratton, E., Prendergast, F.G., 1987. Fluorescence lifetime distributions
in proteins. Biophys. J. 51, 597-604.
Amaro, M., Šachl, R., Jurkiewicz, P., Coutinho, A., Prieto, M., Hof, M., 2014. Time-
resolved fluorescence in lipid bilayers: Selected applications and advantages over
steady state. Biophys. Rev. 107, 2751-2760.
Amiri, M., Jankeje, K., Albani, J.R., 2010a. Characterization of human serum albumin
forms with pH. Fluorescence lifetime studies. J. Pharm. Biomed. Anal. 51, 1097-
1102.
Amiri, M., Jankeje, K., Albani, J.R., 2010b. Origin of fluorescence lifetimes in human
serum albumin. Studies on native and denatured protein. J. Fluoresc. 20, 651-656.
Ariga, G.G., Naik, P.N., Nandibewoor, S.T., Chimatadar, S.A., 2015. Study of
fluorescence interaction and conformational changes of bovine serum albumin
with histamine H1-receptor-drug epinastine hydrochloride by spectroscopic and
time-resolved fluorescence methods. Biopolymers 103, 646-657.
Arnett, D.C., Bailey, S.K., Johnson, C.K., 2018. Exploring the conformations of nitric
326364
oxide synthase with fluorescence. Front. Biosci. 23, 2133-2145.
Aseman, M.D., Aryamanesh, S., Shojaeifard, Z., Hemmateenejad, B., Nabavizadeh,
S.M., 2019. Cycloplatinated(II) derivatives of mercaptopurine capable of binding
interactions with HSA/DNA. Inorg. Chem. 58, 16154-16170.
Barakat, C., Patra, D., 2013. Combining time-resolved fluorescence with synchronous
fluorescence spectroscopy to study bovine serum albumin-curcumin complex
during unfolding and refolding processes. Luminescence 28, 149-155.
Beechem, J.M., Brand, L., 1985. Time-resolved fluorescence of proteins. Annu. Rev.
Biochem. 54, 43-71.
Benabou, S., Ruckebusch, C., Sliwa, M., Aviñó, A., Eritja, R., Gargallo, R., de Juan,
A., 2019. Study of conformational transitions of i-motif DNA using time-resolved
fluorescence and multivariate analysis methods. Nucleic Acids Res. 47, 6590-
6605.
Benson, E.S., Hallaway, B.E., 1970. On the mechanisms of pH-dependent hydrogen
exchange of bovine plasma albumin in the range of pH 5 to 8.5. J. Biol. Chem.
245, 4144-4149.
Berendsen, H.J.C., Postma, J.P.M., van Gunsteren, W.F., DiNola, A., Haak, J.R., 1984.
Molecular dynamics with coupling to an external bath. J. Chem. Phys. 81, 3684-
3690.
Berendsen, H.J.C., van Gunsteren, W.F., Zwinderman, H.R.J., Geurtsen, R.G., 1986.
Simulations of proteins in water. Ann. N. Y. Acad. Sci. 482, 269-286.
Besley, N.A., Hirst, J.D., 1999. Theoretical studies toward quantitative protein
circular dichroism calculations. J. Am. Chem. Soc. 121, 9636-9644.
336566
Bozorgmehr, M.R., Chamani, J., Moslehi, G., 2015. Spectroscopic and DFT
investigation of interactions between cyclophosphamide and aspirin with
lysozyme as binary and ternary systems. J. Biomol. Struct. Dyn. 33, 1669-1681.
Brodersen, R., Sjödin, T., Sjöholm, I., 1977. Independent binding of ligands to human
serum albumin. J. Biol. Chem. 252, 5067-5072.
Burgin, S.R., Oramous, J., Kaminski, M., Stocker, L., Moradi, M., 2018. High school
biology students use of visual molecular dynamics as an authentic tool for
learning about modeling as a professional scientific practice. Biochem. Mol. Biol.
Educ. 46, 230-236.
Carstea, E.M., Popa, C.L., Baker, A., Bridgeman, J., 2019. In situ fluorescence
measurements of dissolved organic matter: A review. Sci. Total Environ. 699,
134361.
Carter, D.C., Chang, B., Ho, J.X., Keeling, K., Krishnasami, Z., 1994a. Preliminary
crystallographic studies of four crystal forms of serum albumin. Eur. J. Biochem.
226, 1049-1052.
Carter, D.C., He, X.M., 1990. Structure of human serum albumin. Science 249, 302-
303.
Carter, D.C., He, X.M., Munson, S.H., Twigg, P.D., Gernert, K.M., Broom, M.B.,
Miller, T.Y., 1989. Three-dimensional structure of human serum albumin. Science
244, 1195-1198.
Carter, D.C., Ho, J.X., 1994b. Structure of serum albumin. Adv. Protein Chem. 45,
153-203.
Chanphai, P., Tajmir-Riahi, H.A., 2019. Conjugation of vitamin C with serum
346768
proteins: A potential application for vitamin delivery. Int. J. Biol. Macromol. 137,
966-972.
Chattopadhyay, A., Haldar, S., 2014. Dynamic insight into protein structure utilizing
red edge excitation shift. Acc. Chem. Res. 47, 12-19.
Chen, R.F., Knutson, J.R., Ziffer, H., Porter, D., 1991. Fluorescence of tryptophan
dipeptides: Correlations with the rotamer model. Biochemistry 30, 5184-5195.
Choi, P.-K., Bae, J.-R., Takagi, K., 1990. Ultrasonic spectroscopy in bovine serum
albumin solutions. J. Acoust. Soc. Am. 87, 874-881.
Choudhury, S.D., Badugu, R., Lakowicz, J.R., 2015. Directing fluorescence with
plasmonic and photonic structures. Acc. Chem. Res. 48, 2171-2180.
Combs, J.A., 1988. Three-stage first-order melting in a two-dimensional lattice: An
isothermal-isobaric molecular-dynamics study. Phys. Rev. Lett. 61, 714-717.
Corrêa, D.H.A., Ramos, C.H.I., 2009. The use of circular dichroism spectroscopy to
study protein folding, form and function. Afr. J. Biochem. Res. 3, 164-173.
Curry, S., 2009. Lessons from the crystallographic analysis of small molecule binding
to human serum albumin. Drug Metab. Pharmacokinet. 24, 342-357.
Darden, T., York, D., Pedersen, L., 1993. Particle mesh Ewald: An N⋅log(N) method
for Ewald sums in large systems. J. Chem. Phys. 98, 10089-10092.
Dockal, M., Carter, D.C., Rüker, F., 1999. The three recombinant domains of human
serum albumin. Structural characterization and ligand binding properties. J. Biol.
Chem. 274, 29303-29310.
Dockal, M., Carter, D.C., Rüker, F., 2000. Conformational transitions of the three
recombinant domains of human serum albumin depending on pH. J. Biol. Chem.
356970
275, 3042-3050.
Dockal, M., Chang, M., Carter, D.C., Rüker, F., 2000. Five recombinant fragments of
human serum albumin-tools for the characterization of the warfarin binding site.
Protein Sci. 9, 1455-1465.
Eftink, M.R., 1991. Fluorescence techniques for studying protein structure, in:
Suelter, C.H. (Eds.), Protein Structure Determination, vol. 35. John Wiley & Sons,
Inc., Hoboken, pp. 127-205.
Eftink, M.R., 1997. Fluorescence methods for studying equilibrium macromolecule-
ligand interactions. Methods Enzymol. 278, 221-257.
Eftink, M.R., Ghiron, C.A., 1981. Fluorescence quenching studies with proteins.
Anal. Biochem. 114, 199-227.
Eftink, M.R., Ghiron, C.A., 1987. Does the fluorescence quencher acrylamide bind to
proteins? Biochim. Biophys. Acta – Protein Struct. Mol. Enzymol. 916, 343-349.
Eftink, M.R., Ghiron, C.A., 1991. On the analysis of the temperature and viscosity
dependence of fluorescence-quenching reactions with proteins. Arch. Biochem.
Biophys. 209, 706-709.
Fasano, M., Curry, S., Terreno, E., Galliano, M., Fanali, G., Narciso, P., Notari, S.,
Ascenzi, P., 2005. The extraordinary ligand binding properties of human serum
albumin. IUBMB Life 57, 787-796.
Flora, K., Brennan, J.D., Baker, G.A., Doody, M.A., Bright, F.V., 1998. Unfolding of
acrylodan-labeled human serum albumin probed by steady-state and time-resolved
fluorescence methods. Biophys. J. 75, 1084-1096.
Ghuman, J., Zunszain, P.A., Petitpas, I., Bhattacharya, A.A., Otagiri, M., Curry, S.,
367172
2005. Structural basis of the drug-binding specificity of human serum albumin. J.
Mol. Biol. 353, 38-52.
Gonze, X., 1996. Towards a potential-based conjugate gradient algorithm for order-N
self-consistent total energy calculations. Phys. Rev. B: Condens. Matter Mater.
Phys. 54, 4383-4386.
Goormaghtigh, E., Gasper, R., Bénard, A., Goldsztein, A., Raussens, V., 2009. Protein
secondary structure content in solution, films and tissues: Redundancy and
complementarity of the information content in circular dichroism, transmission
and ATR FTIR spectra. Biochim. Biophys. Acta – Proteins Proteomics 1794,
1332-1343.
Green, N.J.B., Pimblott, S.M., Tachiya, M., 1993. Generalizations of the Stern-Volmer
relation. J. Phys. Chem. 97, 196-202.
Greenfield, N.J., 2006. Using circular dichroism collected as a function of
temperature to determine the thermodynamics of protein unfolding and binding
interactions. Nat. Protoc. 1, 2527-2535.
Gurd, F.R.N., Rothgeb, T.M., 1979. Motions in proteins. Adv. Protein Chem. 33, 73-
165.
Hansen, M.R., Graf, R., Spiess, H.W., 2013. Solid-state NMR in macromolecular
systems: Insights on how molecular entities move. Acc. Chem. Res. 46, 1996-
2007.
Hao, F., Jing, M.Y., Zhao, X.C., Liu, R.T., 2015. Spectroscopy, calorimetry and
molecular simulation studies on the interaction of catalase with copper ion. J.
Photochem. Photobiol. B: Biol. 143, 100-106.
377374
He, X.M., Carter, D.C., 1992. Atomic structure and chemistry of human serum
albumin. Nature 358, 209-215.
Henry, E., Deprez, E., Brochon, J.-C., 2014. Maximum entropy analysis of data
simulations and practical aspects of time-resolved fluorescence measurements in
the study of molecular interactions. J. Mol. Struct. 1077, 77-86.
Hess, B., Bekker, H., Berendsen, H.J.C., Fraaije, J.G.E.M., 1997. LINCS: A linear
constraint solver for molecular simulations. J. Comput. Chem. 18, 1463-1472.
Hestenes, M.R., Stiefel, E., 1952. Methods of conjugate gradients for solving linear
systems. J. Res. Natl. Bur. Stand. 49, 409-436.
Horváthy, D.B., Simon, M., Schwarz, C.M., Masteling, M., Vácz, G., Hornyák, I.,
Lacza, Z., 2017. Serum albumin as a local therapeutic agent in cell therapy and
tissue engineering. BioFactors 43, 315-330.
Hovius, R., Vallotton, P., Wohland, T., Vogel, H., 2000. Fluorescence techniques:
Shedding light on ligand-receptor interactions. Trends Pharmacol. Sci. 21, 266-
273.
Hsin, J., Arkhipov, A., Yin, Y., Stone, J.E., Schulten, K., 2008. Using VMD: An
introductory tutorial. Curr. Protoc. Bioinformatics 24, 5.7.1-5.7.48.
Huang, W., Lin, Z.X., van Gunsteren, W.F., 2011. Validation of the GROMOS 54A7
force field with respect to β-peptide folding. J. Chem. Theory Comput. 7, 1237-
1243.
Humphrey, W., Dalke, A., Schulten, K., 1996. VMD: Visual molecular dynamics. J.
Mol. Graph. 14, 33-38.
Hvidt, A., Wallevik, K., 1972. Conformational changes in human serum albumin as
387576
revealed by hydrogen-deuterium exchange studies. J. Biol. Chem. 247, 1530-
1535.
Iranfar, H., Rajabi, O., Salari, R., Chamani, J., 2012. Probing the interaction of human
serum albumin with ciprofloxacin in the presence of silver nanoparticles of three
sizes: Multispectroscopic and ζ potential investigation. J. Phys. Chem. B 116,
1951-1964.
Johnson, W.C., 1999. Analyzing protein circular dichroism spectra for accurate
secondary structures. Proteins: Struct. Funct. Genet. 35, 307-312.
Johnson Jr., W.C., 1988. Secondary structure of proteins through circular dichroism
spectroscopy. Annu. Rev. Biophys. Chem. 17, 145-166.
Jorgensen, W.L., Chandrasekhar, J., Madura, J.D., Impey, R.W., Klein, M.L., 1983.
Comparison of simple potential functions for simulating liquid water. J. Chem.
Phys. 79, 926-935.
Julien, O., Wang, G.L., Jonckheer, A., Engelborghs, Y., Sykes, B.D., 2012.
Tryptophan side chain conformers monitored by NMR and time-resolved
fluorescence spectroscopies. Proteins: Struct. Funct. Bioinform. 80, 239-245.
Kelly, S.M., Price, N.C., 2000. The use of circular dichroism in the investigation of
protein structure and function. Curr. Protein Pept. Sci. 1, 349-384.
Kragh-Hansen, U., 1985. Relations between high-affinity binding sites of markers for
binding regions on human serum albumin. Biochem. J. 225, 629-638.
Kragh-Hansen, U., 1988. Evidence for a large and flexible region of human serum
albumin possessing high affinity binding sites for salicylate, warfarin, and other
ligands. Mol. Pharmacol. 34, 160-171.
397778
Kragh-Hansen, U., 1990. Structure and ligand binding properties of human serum
albumin. Dan. Med. Bull. 37, 57-84.
Kragh-Hansen, U., Minchiotti, L., Galliano, M., Peters Jr., T., 2013. Human serum
albumin isoforms: Genetic and molecular aspects and functional consequences.
Biochim. Biophys. Acta – Gen. Subj. 1830, 5405-5417.
Kutzner, C., Czub, J., Grubmüller, H., 2011. Keep it flexible: Driving macromolecular
rotary motions in atomistic simulations with GROMACS. J. Chem. Theory
Comput. 7, 1381-1393.
Kutzner, C., Páll, S., Fechner, M., Esztermann, A., de Groot, B.L., Grubmüller, H.,
2019. More bang for your buck: Improved use of GPU nodes for GROMACS
2018. J. Comput. Chem. 40, 2418-2431.
Lahiri, J., Moemeni, M., Kline, J., Borhan, B., Magoulas, I., Yuwono, S.H., Piecuch,
P., Jackson, J.E., Dantus, M., Blanchard, G.J., 2019. Proton abstraction mediates
interactions between the super photobase FR0-SB and surrounding alcohol
solvent. J. Phys. Chem. B 123, 8448-8456.
Lakowicz, J.R., 2000. On spectral relaxation in proteins. Photochem. Photobiol. 72,
421-437.
Lakowicz, J.R., 2006. Principles of Fluorescence Spectroscopy, third ed. Springer
Science+Business Media, New York.
Lashuel, H.A., Overk, C.R., Oueslati, A., Masliah, E., 2013. The many faces of α-
synuclein: From structure and toxicity to therapeutic target. Nat. Rev. Neurosci.
407980
14, 38-48.
Litus, E.A., Permyakov, S.E., Uversky, V.N., Permyakov, E.A., 2018. Intrinsically
disordered regions in serum albumin: What are they for? Cell Biochem. Biophys.
76, 39-57.
Maity, A., Pal, U., Chakraborty, B., Sengupta, C., Sau, A., Chakraborty, S., Basu, S.,
2019. Preferential photochemical interaction of Ru (III) doped carbon nano dots
with bovine serum albumin over human serum albumin. Int. J. Biol. Macromol.
137, 483-494.
McLaughlin, M.L., Barkley, M.D., 1997. Time-resolved fluorescence of constrained
tryptophan derivatives: Implications for protein fluorescence. Methods Enzymol.
278, 190-202.
Meadows, C.W., Tsang, J.E., Klinman, J.P., 2014. Picosecond-resolved fluorescence
studies of substrate and cofactor-binding domain mutants in a thermophilic
alcohol dehydrogenase uncover an extended network of communication. J. Am.
Chem. Soc. 136, 14821-14833.
Millar, D.P., 2000. Time-resolved fluorescence methods for analysis of DNA-protein
interactions. Methods Enzymol. 323, 442-459.
Moarefi, I., 2016. Protein complex production from the drug discovery standpoint, in:
Vega, M.C. (Eds.), Advanced Technologies for Protein Complex Production and
Characterization, vol. 896. Springer Nature Switzerland AG, Switzerland, pp. 3-
13.
Mohan, V., Sengupta, B., Acharyya, A., Yadav, R., Das, N., Sen, P., 2019. Region-
specific double denaturation of human serum albumin: Combined effects of
418182
temperature and GnHCl on structural and dynamical responses. ACS Omega 3,
10406-10417.
Montero, M.T., Pouplana, R., García, S., Valls, O., 1986. On the binding of
cinmetacin and indomethacin to human serum albumin. J. Pharm. Pharmacol. 38,
925-927.
Moors, S.L.C., Jonckheer, A., De Maeyer, M., Engelborghs, Y., Ceulemans, A., 2008.
How do rotameric conformations influence the time-resolved fluorescence of
tryptophan in proteins? A perspective based on molecular modeling and quantum
chemistry. Curr. Protein Pept. Sci. 9, 427-446.
Mos, I., Jacobsen, S.E., Foster, S.R., Bräuner-Osborne, H., 2019. Calcium-sensing
receptor internalization is β-arrestin-dependent and modulated by allosteric
ligands. Mol. Pharmacol. 96, 463-474.
Munro, I., Pecht, I., Stryer, L., 1979. Subnanosecond motions of tryptophan residues
in proteins. Proc. Natl. Acad. Sci. U. S. A. 76, 56-60.
Neelofar, K., Ahmad, J., 2017. An overview of in vitro and in vivo glycation of
albumin: A potential disease marker in diabetes mellitus. Glycoconj. J. 34, 575-
584.
Nwamba, C.O., Ibrahim, K., 2014. The role of protein conformational switches in
pharmacology: Its implications in metabolic reprogramming and protein
evolution. Cell Biochem. Biophys. 68, 455-462.
Otosu, T., Nishimoto, E., Yamashita, S., 2010. Multiple conformational state of
human serum albumin around single tryptophan residue at various pH revealed by
time-resolved fluorescence spectroscopy. J. Biochem. 147, 191-200.
428384
Pahari, B.P., Chaudhuri, S., Chakraborty, S., Sengupta, P.K., 2015. Ground and
excited state proton transfer of the bioactive plant flavonol robinetin in a protein
environment: Spectroscopic and molecular modeling studies. J. Phys. Chem. B
119, 2533-2545.
Pan, C.-P., Muiño, P.L., Barkley, M.D., Callis, P.R., 2011. Correlation of tryptophan
fluorescence spectral shifts and lifetimes arising directly from heterogeneous
environment. J. Phys. Chem. B 115, 3245-3253.
Patel, B.K., Sepay, N., Mahapatra, A., 2019. Curious results in the prospective
binding interactions of the food additive tartrazine with β-lactoglobulin. Langmuir
35, 11579-11589.
Patel, S., Datta, A., 2007. Steady state and time-resolved fluorescence investigation of
the specific binding of two chlorin derivatives with human serum albumin. J.
Phys. Chem. B 111, 10557-10562.
Periasamy, N., 2008. Heterogeneity of fluorescence determined by the method of
area-normalized time-resolved emission spectroscopy. Methods Enzymol. 450,
21-35.
Pescitelli, G., Bari, L.D., Berova, N., 2014. Application of electronic circular
dichroism in the study of supramolecular systems. Chem. Soc. Rev. 43, 5211-
5233.
Peters Jr., T., 1995. All about Albumin: Biochemistry, Genetics, and Medical
Applications, first ed. Academic Press, Cambridge, Massachusetts.
Petitpas, I., Bhattacharya, A.A., Twine, S., East, M., Curry, S., 2001. Crystal structure
analysis of warfarin binding to human serum albumin: Anatomy of drug site I. J.
438586
Biol. Chem. 276, 22804-22809.
Pinkerton, T.C., Koeplinger, K.A., 1990. Determination of warfarin-human serum
albumin protein binding parameters by an improved Hummel-Dreyer high-
performance liquid chromatographic method using internal surface reversed-phase
columns. Anal. Chem. 62, 2114-2122.
Praus, P., Kočišová, E., Mojzeš, P., Štěpánek, J., Seksek, O., Sureau, F., Turpin, P.-Y.,
2008. Time-resolved microspectrofluorometry and fluorescence imaging
techniques: Study of porphyrin-mediated cellular uptake of oligonucleotides. Ann.
N. Y. Acad. Sci. 1130, 117-121.
Price, D.J., Brooks III, C.L., 2004. A modified TIP3P water potential for simulation
with Ewald summation. J. Chem. Phys. 121, 10096-10103.
Rabbani, G., Ahn, S.N., 2019. Structure, enzymatic activities, glycation and
therapeutic potential of human serum albumin: A natural cargo. Int. J. Biol.
Macromol. 123, 979-990.
Rolinski, O.J., Martin, A., Birch, D.J.S., 2007. Human serum albumin and quercetin
interactions monitored by time-resolved fluorescence: Evidence for enhanced
discrete rotamer conformations. J. Biomed. Opt. 12, 034013.
Ross, J.A., Jameson, D.M., 2008. Time-resolved methods in biophysics. 8. Frequency
domain fluorometry: Applications to intrinsic protein fluorescence. Photochem.
Photobiol. Sci. 7, 1301-1312.
Rull, L.F., de Miguel, E., Morales, J.J., Nuevo, M.J., 1989. Brownian motion in an
isothermal-isobaric bath: Mass and size dependence. Phys. Rev. A: Gen. Phys. 40,
5856-5859.
448788
Ryan, A.J., Chung, C.-W., Curry, S., 2011. Crystallographic analysis reveals the
structural basis of the high-affinity binding of iophenoxic acid to human serum
albumin. BMC Struct. Biol. 11, 18.
Ryan, A.J., Ghuman, J., Zunszain, P.A., Chung, C.-W., Curry, S., 2011. Structural
basis of binding of fluorescent, site-specific dansylated amino acids to human
serum albumin. J. Struct. Biol. 174, 84-91.
Samokhvalov, A.V., Safenkova, I.V., Zherdev, A.V., Dzantiev, B.B., 2018. The
registration of aptamer-ligand (ochratoxin A) interactions based on ligand
fluorescence changes. Biochem. Biophys. Res. Commun. 505, 536-541.
Schmid, N., Eichenberger, A.P., Choutko, A., Riniker, S., Winger, M., Mark, A.E.,
van Gunsteren, W.F., 2011. Definition and testing of the GROMOS force-field
versions 54A7 and 54B7. Eur. Biophys. J. 40, 843-856.
Schneckenburger, H., Seidlitz, H.K., Eberz, J., 1988. New trends in photobiology:
Time-resolved fluorescence in photobiology. J. Photochem. Photobiol. B: Biol. 2,
1-19.
Schüttelkopf, A.W., van Aalten, D.M.F., 2004. PRODRG: A tool for high-throughput
crystallography of protein-ligand complexes. Acta Crystallogr. Sect. D: Struct.
Biol. 60, 1355-1363.
Shakibapour, N., Sani, F.D., Beigoli, S., Sadeghian, H., Chamani, J., 2019. Multi-
spectroscopic and molecular modeling studies to reveal the interaction between
propyl acridone and calf thymus DNA in the presence of histone H1︰binary and
458990
ternary approaches. J. Biomol. Struct. Dyn. 37, 359-371.
Siemiarczuk, A., Petersen, C.E., Ha, C.-E., Yang, J.S., Bhagavan, N.V., 2004.
Analysis of tryptophan fluorescence lifetimes in a series of human serum albumin
mutants with substitutions in subdomain 2 A. Cell Biochem. Biophys. 40, 115-
122.
Simard, J.R., Zunszain, P.A., Hamilton, J.A., Curry, S., 2006. Location of high and
low affinity fatty acid binding sites on human serum albumin revealed by NMR
drug-competition analysis. J. Mol. Biol. 361, 336-351.
Sollenne, N.P., Means, G.E., 1979. Characterization of a specific drug binding site of
human serum albumin. Mol. Pharmacol. 15, 754-757.
Sood, D., Kumar, N., Singh, A., Tomar, V., Dass, S.K., Chandra, R., 2019.
Deciphering the binding mechanism of noscapine with lysozyme: Biophysical and
chemoinformatic approaches. ACS Omega 4, 16233-16241.
Sreerama, N., Woody, R.W., 1994. Protein secondary structure from circular
dichroism spectroscopy: Combining variable selection principle and cluster
analysis with neural network, ridge regression and self-consistent methods. J.
Mol. Biol. 242, 497-507.
Stayton, P.S., Sligar, S.G., 1991. Structural microheterogeneity of a tryptophan
residue required for efficient biological electron transfer between putidaredoxin
and cytochrome P-450CAM. Biochemistry 30, 1845-1851.
Stella, L., 2011. Fluorescence quenching, lifetimes, and fluorophore solvent
accessibility. J. Chem. Educ. 88, 695-696.
Sudlow, G., Birkett, D.J., Wade, D.N., 1973. Spectroscopic techniques in the study of
469192
protein binding: The use of 1-anilino-8-naphthalenesulphonate as a fluorescent
probe for the study of the binding of iophenoxic and iopanoic acids to human
serum albumin. Mol. Pharmacol. 9, 649-657.
Sudlow, G., Birkett, D.J., Wade, D.N., 1975a. Spectroscopic techniques in the study of
protein binding. A fluorescence technique for the evaluation of the albumin
binding and displacement of warfarin and warfarin-alcohol. Clin. Exp. Pharmacol.
Physiol. 2, 129-140.
Sudlow, G., Birkett, D.J., Wade, D.N., 1975b. The characterization of two specific
drug binding sites on human serum albumin. Mol. Pharmacol. 11, 824-832.
Sudlow, G., Birkett, D.J., Wade, D.N., 1976. Further characterization of specific drug
binding sites on human serum albumin. Mol. Pharmacol. 12, 1052-1061.
Szabo, A.G., Rayner, D.M., 1980. The time resolved emission spectra of peptide
conformers measured by pulsed laser excitation. Biochem. Biophys. Res.
Commun. 94, 909-915.
Tarif, E., Mondal, J., Biswas, R., 2019. Interaction and dynamics in a fully
biodegradable glucose-containing naturally abundant deep eutectic solvent:
Temperature-dependent time-resolved fluorescence measurements. J. Phys. Chem.
B 123, 9378-9387.
Tillement, J.-P., Zini, R., Lecomte, M., d’Athis, P., 1980. Binding of digitoxin,
digoxin and gitoxin to human serum albumin. Eur. J. Drug Metab. Pharmacokinet.
5, 129-134.
Valadan, M., Pomarico, E., Ventura, B.D., Gesuele, F., Velotta, R., Amoresano, A.,
Pinto, G., Chergui, M., Improta, R., Altucci, C., 2019. A multi-scale time-resolved
479394
study of photoactivated dynamics in 5-benzyl uracil, a model for DNA/protein
interactions. Phys. Chem. Chem. Phys. 21, 26301-26310.
van Aalten, D.M.F., Bywater, R., Findlay, J.B.C., Hendlich, M., Hooft, R.W.W.,
Vriend, G., 1996. PRODRG, a program for generating molecular topologies and
unique molecular descriptors from coordinates of small molecules. J. Comput.-
Aided Mol. Des. 10, 255-262.
van der Spoel, D., Lindahl, E., Hess, B., Groenhof, G., Mark, A.E., Berendsen, H.J.,
2005. GROMACS: Fast, flexible, and free. J. Comput. Chem. 26, 1701-1718.
van Gunsteren, W.F., Berendsen, H.J.C., 1984. Computer simulation as a tool for
tracing the conformational differences between proteins in solution and in the
crystalline state. J. Mol. Biol. 176, 559-564.
Volynskaya, A.V., Kasumov, E.A., Bogascheva, E.N., Shishkov, A.V., Goldanskii,
V.I., 1994. Determination of the accessible surface of globular proteins by means
of tritium planigraphy. Eur. Biophys. J. 23, 139-143.
Wallace, B.A., Janes, R.W., 2001. Synchrotron radiation circular dichroism
spectroscopy of proteins: Secondary structure, fold recognition and structural
genomics. Curr. Opin. Chem. Biol. 5, 567-571.
Wang, Z.-M., Ho, J.X., Ruble, J.R., Rose, J., Rüker, F., Ellenburg, M., Murphy, R.,
Click, J., Soistman, E., Wilkerson, L., Carter, D.C., 2013. Structural studies of
several clinically important oncology drugs in complex with human serum
albumin. Biochim. Biophys. Acta – Gen. Subj. 1830, 5356-5374.
Weber, G., 1972. Ligand binding and internal equilibria in proteins. Biochemistry 11,
864-878.
489596
Weber, G., 1975. Energetics of ligand binding to proteins. Adv. Protein Chem. 29, 1-
83.
Williams, J.K., Zhang, Y., Schmidt-Rohr, K., Hong, M., 2013. pH-Dependent
conformation, dynamics, and aromatic interaction of the gating tryptophan residue
of the influenza M2 proton channel from solid-state NMR. Biophys. J. 104, 1698-
1708.
Willumsen, L., 1971. Hydrogen isotope exchange in the study of protein
conformation. A quantitative test of an exchange mechanism. Compt. Rend. Trav.
Lab. Carlsberg 38, 223-295.
Woody, R.W., 1995. Circular dichroism. Methods Enzymol. 246, 34-71.
Wu, T.Q., Oake, J., Liu, Z.D., Bohne, C., Branda, N.R., 2018. Probing the
microenvironments in a polymer-wrapped core-shell nanoassembly using pyrene
chromophores. ACS Omega 3, 7673-7680.
Xie, X.Y., Wang, Z.W., Zhou, X.M., Wang, X.R., Chen, X.G., 2011. Study on the
interaction of phthalate esters to human serum albumin by steady-state and time-
resolved fluorescence and circular dichroism spectroscopy. J. Hazard. Mater. 192,
1291-1298.
Yamasaki, K., Maruyama, T., Kragh-Hansen, U., Otagiri, M., 1996. Characterization
of site I on human serum albumin: Concept about the structure of a drug binding
site. Biochim. Biophys. Acta – Protein Struct. Mol. Enzymol. 1295, 147-157.
Yang, C.M., Zhang, J., 2010. Insights into intramolecular Trp and His side-chain
orientation and stereospecific π interactions surrounding metal centers: An
investigation using protein metal‐site mimicry in solution. Chem. – A Eur. J. 16,
499798
10854-10865.
York, D.M., Wlodawer, A., Pedersen, L.G., Darden, T.A., 1994. Atomic-level
accuracy in simulations of large protein crystals. Proc. Natl. Acad. Sci. U. S. A.
91, 8715-8718.
Zahid, N.I., Ji, L., Khyasudeen, M.F., Friedrich, A., Hashim, R., Marder, T.B., Abou-
Zied, O.K., 2019. Evidence of increased hydrophobicity and dynamics inside the
tail region of glycolipid self-assemblies using 2-n-alkyl-pyrene derivatives to
probe different locations. Langmuir 35, 9584-9592.
Zhao, X.C., Liu, R.T., Chi, Z.X., Teng, Y., Qin, P.F., 2010. New insights into the
behavior of bovine serum albumin adsorbed onto carbon nanotubes:
Comprehensive spectroscopic studies. J. Phys. Chem. B 114, 5625-5631.
Žoldák, G., Jancura, D., Sedlák, E., 2017. The fluorescence intensities ratio is not a
reliable parameter for evaluation of protein unfolding transitions. Protein Sci. 26,
1236-1239.
Zunszain, P.A., Ghuman, J., McDonagh, A.F., Curry, S., 2008. Crystallographic
analysis of human serum albumin complexed with 4Z,15E-bilirubin-IXα. J. Mol.
Biol. 381, 394-406.
5099100